Cite
Saito S, Kojima S, Oishi N, et al. A multicenter, randomized, placebo-controlled trial for cilostazol in patients with mild cognitive impairment: The COMCID study protocol. Alzheimers Dement (N Y). 2016;2(4):250-257doi: 10.1016/j.trci.2016.10.001.
Saito, S., Kojima, S., Oishi, N., Kakuta, R., Maki, T., Yasuno, F., Nagatsuka, K., Yamamoto, H., Fukuyama, H., Fukushima, M., & Ihara, M. (2016). A multicenter, randomized, placebo-controlled trial for cilostazol in patients with mild cognitive impairment: The COMCID study protocol. Alzheimer's & dementia (New York, N. Y.), 2(4), 250-257. https://doi.org/10.1016/j.trci.2016.10.001
Saito, Satoshi, et al. "A multicenter, randomized, placebo-controlled trial for cilostazol in patients with mild cognitive impairment: The COMCID study protocol." Alzheimer's & dementia (New York, N. Y.) vol. 2,4 (2016): 250-257. doi: https://doi.org/10.1016/j.trci.2016.10.001
Saito S, Kojima S, Oishi N, Kakuta R, Maki T, Yasuno F, Nagatsuka K, Yamamoto H, Fukuyama H, Fukushima M, Ihara M. A multicenter, randomized, placebo-controlled trial for cilostazol in patients with mild cognitive impairment: The COMCID study protocol. Alzheimers Dement (N Y). 2016 Oct 27;2(4):250-257. doi: 10.1016/j.trci.2016.10.001. eCollection 2016 Nov. PMID: 29067312; PMCID: PMC5651350.
Copy
Download .nbib